Slingshot Insights

Catalyst

Slingshot members are tracking this event:

Initial data from the ORION-1 Phase 2 study on ALN-PCSsc are expected to be presented by The Medicines Company (MDCO) on November 15, 2016

Source Link:: http://investors.alnylam.com/releasedetail.cfm?ReleaseID=949685

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

MDCO

100%

ALNY

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details It was initially expected to be presented in late 2016, but a company update on 5 Oct 2016 made it known that data will be presented in in Late-Breaking Clinical Trial Session at American Heart Association (AHA) meeting on November 15, 2016

http://www.themedici...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Nov 15, 2016

Occurred Source:

https://www.sec.gov/Archives/edgar/data/1113481/000110465916157180/a16-21669_1ex99d2.htm

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Initial Data, Orion-1, Phase 2 Study